These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3244409)
1. Effects of apomorphine in quantified electroencephalography in the frontal cortex: changes with dose and time. Shvaloff A; Tesolin B; Sebban C Neuropharmacology; 1988 Dec; 27(12):1313-7. PubMed ID: 3244409 [TBL] [Abstract][Full Text] [Related]
2. Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors. Kropf W; Kuschinsky K; Krieglstein J Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):718-25. PubMed ID: 2699354 [TBL] [Abstract][Full Text] [Related]
3. Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat. Ferrer JM; Sanguinetti AM; Vives F; Mora F Pharmacol Biochem Behav; 1983 Aug; 19(2):211-7. PubMed ID: 6138775 [TBL] [Abstract][Full Text] [Related]
4. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons. Kerkerian L; Nieoullon A Exp Brain Res; 1988; 69(2):424-30. PubMed ID: 2894320 [TBL] [Abstract][Full Text] [Related]
5. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats. Bagetta G; De Sarro G; Priolo E; Nisticò G Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741 [TBL] [Abstract][Full Text] [Related]
6. Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390. Gessa GL; Porceddu ML; Collu M; Mereu G; Serra M; Ongini E; Biggio G Eur J Pharmacol; 1985 Feb; 109(2):269-74. PubMed ID: 2859998 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of hydrated fullerene C60: cortical and hippocampal EEG interplay in an amyloid-infused rat model of Alzheimer's disease. Vorobyov V; Kaptsov V; Gordon R; Makarova E; Podolski I; Sengpiel F J Alzheimers Dis; 2015; 45(1):217-33. PubMed ID: 25589720 [TBL] [Abstract][Full Text] [Related]
8. Sleep induced by low doses of apomorphine in rats. Mereu GP; Scarnati E; Paglietti E; Quarantotti BP; Chessa P; Di Chiara G; Gessa GL Electroencephalogr Clin Neurophysiol; 1979 Feb; 46(2):214-9. PubMed ID: 86429 [TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity to apomorphine and clonidine following frontal cortical damage in rats. Glick SD; Cox R Eur J Pharmacol; 1976 Mar; 36(1):241-5. PubMed ID: 1261598 [TBL] [Abstract][Full Text] [Related]
10. Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming. Morelli M; Fenu S; Cozzolino A; Di Chiara G Neuroscience; 1991; 42(1):41-8. PubMed ID: 1830642 [TBL] [Abstract][Full Text] [Related]
11. Prefrontal cortex and neostriatum self-stimulation in the rat: differential effects produced by apomorphine. Mora F; Phillips AG; Koolhaas JM; Rolls ET Brain Res Bull; 1976; 1(5):421-4. PubMed ID: 1009443 [TBL] [Abstract][Full Text] [Related]
12. Amplitude and spectral quantification of the effects of morphine on the cortical EEG of the rat. Bronzino JD; Kelly ML; Cordova C; Gudz M; Oley N; Stern WC; Morgane PJ Electroencephalogr Clin Neurophysiol; 1982 Jan; 53(1):14-26. PubMed ID: 6173197 [TBL] [Abstract][Full Text] [Related]
13. Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors. Kropf W; Kuschinsky K Neuropharmacology; 1991 Sep; 30(9):953-60. PubMed ID: 1681452 [TBL] [Abstract][Full Text] [Related]
14. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites. Herrera-Marschitz M; Ungerstedt U Eur J Pharmacol; 1984 Feb; 98(2):165-76. PubMed ID: 6143675 [TBL] [Abstract][Full Text] [Related]
15. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect. Verma A; Kulkarni SK; Nayar U Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945 [TBL] [Abstract][Full Text] [Related]
16. Conditioning of apomorphine effects: simultaneous analysis of the alterations in cortical electroencephalogram and behaviour. Kropf W; Kuschinsky K; Krieglstein J Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):559-67. PubMed ID: 1944603 [TBL] [Abstract][Full Text] [Related]
17. Effects of pretreatment with luteinizing hormone releasing hormone (LHRH) on behaviors induced by apomorphine in rats. Mora S; Diaz-Veliz G Pharmacol Biochem Behav; 1988 Oct; 31(2):291-6. PubMed ID: 3072567 [TBL] [Abstract][Full Text] [Related]
18. EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease. Vorobyov VV; Schibaev NV; Morelli M; Carta AR Brain Res; 2003 May; 972(1-2):177-85. PubMed ID: 12711091 [TBL] [Abstract][Full Text] [Related]
19. Effects of stimulation of dopamine D1 receptors on the cortical EEG in rats: different influences by a blockade of D2 receptors and by an activation of putative dopamine autoreceptors. Kropf W; Kuschinsky K Neuropharmacology; 1993 May; 32(5):493-500. PubMed ID: 8321430 [TBL] [Abstract][Full Text] [Related]
20. Time course and regional basis of Pb-induced changes in MK-801 binding: reversal by chronic treatment with the dopamine agonist apomorphine but not the D1 agonist SKF-82958. Cory-Slechta DA; McCoy L; Richfield EK J Neurochem; 1997 May; 68(5):2012-23. PubMed ID: 9109527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]